查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2084931

心房顫動手術市場：依手術類型、能源來源、適應症、手術方法和最終用戶分類－2026-2032年全球市場預測

Atrial Fibrillation Surgery Market by Procedure Type, Energy Source, Indication, Surgical Approach, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，心房顫動手術市場將成長至 59.8 億美元，複合年成長率為 9.56%。

主要市場統計數據
基準年 2025 31.5億美元
預計年份：2026年 34.3億美元
預測年份 2032 59.8億美元
複合年成長率 (%) 9.56%

心房顫動手術正從心血管手術的小眾領域轉變為電生理學和結構性心臟治療領域的策略性成長點。心房顫動是最常見的持續性心律不整，根據全球疾病負擔調查，2019年估計有超過5,900萬人患有心房顫動或心房撲動。人口老化、高血壓、肥胖、糖尿病、睡眠呼吸中止症和心臟衰竭的增加，擴大了需要治療的患者群體，並提高了對旨在持續控制心律的療法的需求。

心房顫動手術市場涵蓋了多種手術方式，包括 Cox-Maze IV 手術方法的消融術、微創胸腔鏡消融術、心外膜-心內膜混合手術、瓣膜手術或冠狀動脈繞道術期間的平行消融術以及左心耳處理術。需求量最大的領域是心臟外科、電生理學、先進影像學、手術全期風預防以及基於療效的報銷機制的交叉領域。

心房顫動手術領域的變革性變化

該領域的治療格局正從開胸手術和縫合轉向能量輔助消融、微創手術、混合燒灼術技術以及綜合性心律不整治療方案。雖然最新的射頻消融和冷凍消融平台提高了手術的一致性，但多學科心臟團隊正在拓展持續性和長期持續性心房顫動的治療選擇，尤其是在已接受心血管手術的患者中。

人工智慧（AI）的累積影響

人工智慧 (AI) 正成為心房顫動手術整個價值鏈中的一股協同力量。 AI 驅動的心電圖分析、影像分割和風險分層有助於識別可能從早期節律控制干預中獲益的患者。預測模型也能為消融策略、左心房大小、纖維化程度、抗凝血治療需求、復發風險等方面的決策提供支援。

主要區域洞察

由於亞太地區人口眾多、人口老化速度加快，以及中國、印度、日本、韓國和澳洲等國心血管疾病風險不斷上升，預計該地區將擁有強勁的長期需求。日本和澳洲受益於成熟的心臟外科基礎設施、完善的專科轉診體系和先進的電生理治療能力。同時，中國和印度正在擴建三級心臟中心和心律不整治療體系，從而為外科消融術、混合手術和左心耳封堵術等治療手段的普及提供了支持。

關鍵的群體特定見解

東協市場正透過醫院現代化、醫療旅遊和電生理培訓的擴展而發展，新加坡、泰國和馬來西亞已成為複雜心血管治療的區域外科中心。海灣合作理事會（GCC）國家正投資於先進的心血管醫療服務、三級醫療設施和專業人才培養，這為高階外科消融系統、混合手術室以及與國際知名醫療中心的合作創造了機會。

主要國家的概況

美國是心房顫動手術商業性，這得益於其心房顫動的高發病率、專業的電生理項目、醫療保險覆蓋範圍、先進的影像技術以及微創和混合心血管手術的廣泛應用。在加拿大，透過公立心臟中心和實證轉診途徑，心房顫動手術正穩定發展。而在墨西哥和巴西，隨著私立和公立心血管中心投資建構先進的心律不整治療能力，都會大都會圈的治療機會也不斷擴大。

為行業領導者提供的實用建議

產業領導者應優先考慮整合心房顫動治療方案，將心臟外科醫師、電生理學家、影像專家、中風預防團隊、麻醉師和數位監測平台整合起來。能夠證明患者持續竇性心律、中風風險降低、再次手術次數減少、併發症減少以及生活品質提高的機構，將在以價值為導向的採購環境中佔據更有利的地位。

調查方法

本研究採用符合既定產業研究標準的二手資料及一手資料蒐集方式。研究內容涵蓋同行評審的循環系統和心胸外科文獻、專業學會指南、公共衛生資料庫、監管文件、醫院採購趨勢、治療過程評估以及醫療設備核准資訊。

結論

隨著心房顫動盛行率的上升以及支持更早期、更全面的節律控制策略的證據不斷積累，心房顫動手術預計仍將是心血管醫學領域的高價值研究方向。其在臨床實踐中的應用將受到微創外科消融術、混合技術、心血管手術中並行消融術、左心耳管理、數位監測以及人工智慧輔助的患者篩選等因素的影響。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：心房顫動手術市場：依手術類型分類

  • 心導管電氣燒灼術
  • 混合燒灼術
  • 外科迷宮

第8章：心房顫動手術市場：依能源來源分類

  • 冷凍消融術
  • 雷射
    • 準分子雷射
    • 鈥雷射
  • 高頻
  • 超音波
    • 高強度聚焦超音波
    • 血管內超音波

第9章：心房顫動手術市場：依適應症分類

  • 陣發性
  • 永久
  • 持續
    • 持久
    • 短期持續型

第10章：心房顫動手術市場：依手術方法分類

  • 開胸手術
  • 微創手術

第11章：心房顫動手術市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專業心臟病中心

第12章：心房顫動手術市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：心房顫動手術市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：心房顫動手術市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abbott Laboratories
  • Acutus Medical, Inc
  • Affera, Inc.
  • AFreeze GmbH
  • Atrian Medical Ltd.
  • AtriCure, Inc.
  • AuriGen Medical
  • BIOTRONIK SE & CO. KG
  • Boston Scientific Corporation
  • Cardiofocus, Inc.
  • CathRx Ltd
  • Cook Group Incorporated
  • F. Hoffmann-La Roche AG
  • GE HealthCare Technologies Inc.
  • Healium Medical
  • Japan Lifeline Co.
  • Johnson & Johnson Services, Inc.
  • Kardium Inc.
  • Koninklijke Philips NV
  • Medtronic PLC
  • Osypka AG
  • SentiAR, Inc
  • Siemens Healthcare GmbH
  • Stryker Corporation
  • Terumo Corporation
  • Toray Medical Co., Ltd.
  • Vanguard AG
  • Volta Medical
Product Code: MRR-436901065DB6

The Atrial Fibrillation Surgery Market is projected to grow by USD 5.98 billion at a CAGR of 9.56% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.15 billion
Estimated Year [2026] USD 3.43 billion
Forecast Year [2032] USD 5.98 billion
CAGR (%) 9.56%

Atrial fibrillation surgery is moving from a niche cardiac procedure category to a strategic growth area within electrophysiology and structural heart care. Atrial fibrillation is the most common sustained cardiac arrhythmia, and the Global Burden of Disease study estimated that more than 59 million people were living with atrial fibrillation or atrial flutter in 2019. Rising age, hypertension, obesity, diabetes, sleep apnea, and heart failure are expanding the eligible patient pool and increasing demand for durable rhythm-control interventions.

The atrial fibrillation surgery market includes Cox-Maze IV surgical ablation, minimally invasive thoracoscopic ablation, hybrid epicardial-endocardial procedures, concomitant ablation during valve or coronary artery bypass surgery, and left atrial appendage management. Demand is strongest where cardiac surgery, electrophysiology, advanced imaging, perioperative stroke prevention, and outcomes-based reimbursement intersect.

Transformative Shifts in the Atrial Fibrillation Surgery Landscape

The landscape is shifting from open cut-and-sew surgery toward energy-based lesion creation, minimally invasive access, hybrid ablation pathways, and integrated rhythm-care programs. Modern radiofrequency and cryoablation platforms have improved procedural consistency, while multidisciplinary heart teams are expanding treatment options for persistent and long-standing persistent atrial fibrillation, particularly in patients already undergoing cardiac surgery.

Clinical guidance is also shaping adoption. The 2023 ACC/AHA/ACCP/HRS atrial fibrillation guideline supports surgical ablation during selected cardiac surgeries and emphasizes stroke-risk reduction strategies, including left atrial appendage management in appropriate patients. At the same time, remote monitoring, implantable loop recorders, and digital follow-up are improving recurrence detection and creating stronger evidence for durable rhythm control, patient selection, and post-operative care pathways.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a compounding force across the atrial fibrillation surgery value chain. AI-enabled ECG interpretation, imaging segmentation, and risk stratification can help identify patients who may benefit from earlier rhythm-control intervention, while predictive models support decisions around ablation strategy, left atrial size, fibrosis burden, anticoagulation needs, and recurrence risk.

In the operating room and hybrid lab, AI is expected to improve workflow planning, lesion assessment, mapping integration, and quality assurance. Post-procedure, machine learning can analyze wearable and remote-monitoring data to detect recurrence faster than episodic follow-up. The greatest near-term value will come from validated clinical decision support, transparent algorithms, cybersecurity, clinician oversight, and compliance with medical-device regulations.

Key Regional Insights

Asia-Pacific is positioned for strong long-term demand because of population scale, rapid aging, and rising cardiovascular risk in China, India, Japan, South Korea, and Australia. Japan and Australia benefit from mature cardiac surgery infrastructure, established specialist referral systems, and advanced electrophysiology capabilities, while China and India are expanding tertiary cardiac centers and rhythm-care capacity, supporting broader access to surgical ablation, hybrid procedures, and left atrial appendage management.

North America remains a leading innovation and adoption region, supported by advanced hospital networks, specialist electrophysiology programs, FDA-regulated device pathways, high use of remote monitoring, and strong implementation of evidence-based guidelines. Europe benefits from high procedural expertise, national cardiac registries, and harmonized clinical practice under European professional societies, with adoption supported by structured cardiac care pathways and outcomes reporting. Latin America, led by Brazil and Mexico, is expanding access through major urban cardiac centers, although reimbursement consistency, specialist availability, and advanced device access vary across health systems. The Middle East is gaining momentum through GCC investments in tertiary hospitals, cardiovascular centers, and medical technology adoption, while Africa remains underpenetrated due to limited cardiac surgery capacity, uneven access to rhythm-care diagnostics, and shortages of trained electrophysiology and cardiothoracic surgery teams.

Key Group Insights

ASEAN markets are advancing through hospital modernization, medical tourism, and growing electrophysiology training, with Singapore, Thailand, and Malaysia serving as regional procedure hubs for complex cardiovascular care. The GCC is investing in high-acuity cardiovascular services, tertiary hospitals, and specialist workforce development, creating opportunities for premium surgical ablation systems, hybrid operating rooms, and partnerships with international centers of excellence.

The European Union offers scale through standardized regulatory expectations, strong clinical networks, and adoption of guideline-driven care, although EU Medical Device Regulation requirements have increased evidence, post-market surveillance, and compliance burdens for manufacturers. BRICS countries represent high-volume potential because of large atrial fibrillation populations, aging demographics, and expanding tertiary care, but pricing, procurement, training, and access strategies must be localized. G7 markets remain the benchmark for innovation, reimbursement evidence, clinical trial activity, and premium device adoption, while NATO-aligned health systems increasingly emphasize supply resilience, interoperability, cybersecurity, and trusted clinical technologies for critical cardiovascular care.

Key Country Insights

The United States is the most commercially advanced market for atrial fibrillation surgery, supported by high atrial fibrillation prevalence, specialized electrophysiology programs, Medicare coverage pathways, advanced imaging, and strong uptake of minimally invasive and hybrid cardiac procedures. Canada shows steady adoption through publicly funded cardiac centers and evidence-based referral pathways, while Mexico and Brazil are expanding access in large metropolitan hospitals where private and public cardiovascular centers are investing in advanced rhythm-care capabilities.

In Europe, the United Kingdom, Germany, France, Italy, and Spain benefit from established cardiac surgery networks, guideline-based rhythm management, and growing use of multidisciplinary atrial fibrillation programs, with Germany standing out for procedural capacity, hospital density, and device evaluation infrastructure. Russia has a sizable cardiovascular burden but faces procurement, access, and technology availability constraints that can affect adoption consistency. China and India offer the largest long-term volume opportunity as tertiary hospitals scale advanced rhythm care, cardiothoracic surgery, and electrophysiology services for large patient populations. Japan and South Korea combine aging demographics with high technology adoption, advanced hospital infrastructure, and strong clinical expertise, while Australia maintains robust outcomes infrastructure, specialist access across major urban centers, and established use of guideline-directed cardiovascular care.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize integrated atrial fibrillation programs that connect cardiac surgeons, electrophysiologists, imaging specialists, stroke-prevention teams, anesthesiology, and digital monitoring platforms. Organizations that demonstrate durable sinus rhythm, lower stroke risk, fewer repeat interventions, reduced complications, and improved quality of life will be better positioned in value-based procurement environments.

Strategic actions include investing in physician training for hybrid ablation, building real-world evidence registries, designing devices for reproducible transmural lesion creation, and aligning AI tools with regulatory-grade validation. Manufacturers should localize pricing, training, service, and maintenance models for emerging markets, while hospitals should track recurrence, complications, length of stay, readmissions, anticoagulation outcomes, and patient-reported quality-of-life measures to strengthen reimbursement discussions and improve patient selection.

Research Methodology

The research approach applies secondary and primary intelligence methods aligned with established industry research standards. Inputs include peer-reviewed cardiology and cardiothoracic surgery literature, professional society guidelines, public health databases, regulatory documents, hospital purchasing patterns, procedure pathway assessments, and device approval information.

Findings are triangulated across clinical evidence, epidemiology, reimbursement conditions, installed procedure capacity, regulatory status, physician adoption patterns, and regional access dynamics. Interpretation emphasizes verified, data-backed indicators such as atrial fibrillation prevalence, cardiac surgery volumes, technology adoption, guideline recommendations, safety outcomes, and real-world evidence. Qualitative insights are validated through expert review and cross-comparison to avoid unsupported claims, market sizing, or speculative forecasting.

Conclusion

Atrial fibrillation surgery is set to remain a high-value segment of cardiovascular care as disease prevalence rises and evidence supports earlier, more integrated rhythm-control strategies. Clinical adoption will be shaped by minimally invasive surgical ablation, hybrid procedures, concomitant ablation during cardiac surgery, left atrial appendage management, digital monitoring, and AI-enabled patient selection.

The most successful organizations will combine clinical rigor with operational scalability. Markets with strong specialist networks, reimbursement clarity, regulatory preparedness, and outcomes tracking will lead adoption, while emerging regions will require affordability, training, infrastructure investment, and reliable follow-up systems. Across all regions, durable outcomes, validated evidence, and multidisciplinary care delivery will define competitive advantage in atrial fibrillation surgery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Atrial Fibrillation Surgery Market, by Procedure Type

  • 7.1. Catheter Ablation
  • 7.2. Hybrid Ablation
  • 7.3. Surgical Maze

8. Atrial Fibrillation Surgery Market, by Energy Source

  • 8.1. Cryoablation
  • 8.2. Laser
    • 8.2.1. Excimer Laser
    • 8.2.2. Holmium Laser
  • 8.3. Radiofrequency
  • 8.4. Ultrasound
    • 8.4.1. High-Intensity Focused Ultrasound
    • 8.4.2. Intravascular Ultrasound

9. Atrial Fibrillation Surgery Market, by Indication

  • 9.1. Paroxysmal
  • 9.2. Permanent
  • 9.3. Persistent
    • 9.3.1. Long-Standing Persistent
    • 9.3.2. Short-Term Persistent

10. Atrial Fibrillation Surgery Market, by Surgical Approach

  • 10.1. Open-Heart Surgery
  • 10.2. Minimally Invasive Surgery

11. Atrial Fibrillation Surgery Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialty Cardiac Centers

12. Atrial Fibrillation Surgery Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Atrial Fibrillation Surgery Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Atrial Fibrillation Surgery Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abbott Laboratories
  • 16.2. Acutus Medical, Inc
  • 16.3. Affera, Inc.
  • 16.4. AFreeze GmbH
  • 16.5. Atrian Medical Ltd.
  • 16.6. AtriCure, Inc.
  • 16.7. AuriGen Medical
  • 16.8. BIOTRONIK SE & CO. KG
  • 16.9. Boston Scientific Corporation
  • 16.10. Cardiofocus, Inc.
  • 16.11. CathRx Ltd
  • 16.12. Cook Group Incorporated
  • 16.13. F. Hoffmann-La Roche AG
  • 16.14. GE HealthCare Technologies Inc.
  • 16.15. Healium Medical
  • 16.16. Japan Lifeline Co.
  • 16.17. Johnson & Johnson Services, Inc.
  • 16.18. Kardium Inc.
  • 16.19. Koninklijke Philips N.V.
  • 16.20. Medtronic PLC
  • 16.21. Osypka AG
  • 16.22. SentiAR, Inc
  • 16.23. Siemens Healthcare GmbH
  • 16.24. Stryker Corporation
  • 16.25. Terumo Corporation
  • 16.26. Toray Medical Co., Ltd.
  • 16.27. Vanguard AG
  • 16.28. Volta Medical

LIST OF FIGURES

  • FIGURE 1. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CATHETER ABLATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CATHETER ABLATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CATHETER ABLATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HYBRID ABLATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HYBRID ABLATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HYBRID ABLATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL MAZE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL MAZE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL MAZE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CRYOABLATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CRYOABLATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CRYOABLATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LASER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LASER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL LASER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL EXCIMER LASER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL EXCIMER LASER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL EXCIMER LASER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HOLMIUM LASER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HOLMIUM LASER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HOLMIUM LASER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RADIOFREQUENCY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RADIOFREQUENCY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RADIOFREQUENCY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ULTRASOUND MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ULTRASOUND MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HIGH-INTENSITY FOCUSED ULTRASOUND MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HIGH-INTENSITY FOCUSED ULTRASOUND MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HIGH-INTENSITY FOCUSED ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PAROXYSMAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PAROXYSMAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PAROXYSMAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERMANENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERMANENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERMANENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERSISTENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERSISTENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERSISTENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL LONG-STANDING PERSISTENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL LONG-STANDING PERSISTENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL LONG-STANDING PERSISTENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SHORT-TERM PERSISTENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SHORT-TERM PERSISTENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SHORT-TERM PERSISTENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL OPEN-HEART SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL OPEN-HEART SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL OPEN-HEART SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SPECIALTY CARDIAC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SPECIALTY CARDIAC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SPECIALTY CARDIAC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. GCC ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 136. GCC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. GCC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 138. GCC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 139. GCC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 140. GCC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 141. GCC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2018-2032 (USD MILLION)
  • TABLE 142. GCC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 143. GCC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. G7 ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 163. G7 ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. G7 ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 165. G7 ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 166. G7 ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 167. G7 ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 168. G7 ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2018-2032 (USD MILLION)
  • TABLE 169. G7 ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 170. G7 ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. NATO ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 172. NATO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. NATO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 174. NATO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 175. NATO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 176. NATO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 177. NATO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2018-2032 (USD MILLION)
  • TABLE 178. NATO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 179. NATO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 193. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 194. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 195. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 196. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2018-2032 (USD MILLION)
  • TABLE 197. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 198. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 202. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 203. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 204. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 205. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2018-2032 (USD MILLION)
  • TABLE 206. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 207. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 211. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 212. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 213. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 214. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2018-2032 (USD MILLION)
  • TABLE 215. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 216. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 229. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 230. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 231. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 232. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2018-2032 (USD MILLION)
  • TABLE 233. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 234. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 238. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 239. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 240. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 241. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2018-2032 (USD MILLION)
  • TABLE 242. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 243. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 247. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 248. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 249. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 250. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2018-2032 (USD MILLION)
  • TABLE 251. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 252. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 256. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 257. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 258. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 259. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2018-2032 (USD MILLION)
  • TABLE 260. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 261. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 265. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 266. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 267. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 268. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2018-2032 (USD MILLION)
  • TABLE 269. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 270. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 281. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 283. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 284. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 285. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 286. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2018-2032 (USD MILLION)
  • TABLE 287. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 288. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 289. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 290. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 292. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 293. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 294. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 295. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2018-2032 (USD MILLION)
  • TABLE 296. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 297. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 298. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 299. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 301. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 302. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 303. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 304. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2018-2032 (USD MILLION)
  • TABLE 305. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 306. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 307. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 308. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 310. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 311. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 312. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 313. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2018-2032 (USD MILLION)
  • TABLE 314. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 315. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)